Item 1.02 Termination of a Material Definitive Agreement.
Further to the Current Report on Form 8-K dated July 5, 2022, the closing
conditions for the Manufacturing and Supply Agreement between ALR Technologies
SG Pte. Ltd. ("ALRS"), an affiliate of ALR Technologies Inc. (the "Company"),
and Infinovo Medical Co., Ltd. were not met and that agreement has now
terminated. The parties are now working on completing a new agreement whereby
the closing condition for ALRS to enter into a binding sales and distribution
agreement for the GluCurve Pet CGM would be August 31, 2022. Should the parties
enter into a new manufacturing and supply agreement, it will not become
effective unless ALRS enters into a binding distribution agreement for the sale
and distribution of GluCurve by August 31, 2022. There can be no assurance that
the parties will enter in such new agreement or that this condition to
effectiveness of the new agreement will be satisfied.
Item 7.01 Regulation FD Disclosure.
On August 1, 2022, the Company issued a press release titled "ALR Technologies
Announces First Shipment of GluCurve Pet CGMs Expected in October and Update on
the Manufacturing Agreement."
A copy of this press release is filed as Exhibit 99.1 to this Current Report on
Form 8-K and is incorporated herein by reference.
© Edgar Online, source Glimpses